Specialty Pharmacy Network

Specialty Pharmacy Network
How to Prescribe
Transition Pharmacy Services

Services patients nationwide

Call (877) 527-3927 Option 1

Fax (877) 594-4906

Hours

Monday-Friday:
8 am-8 pm (ET)

Beach Terrace Pharmacy

Services patients in AZ, CA

Call (714) 786-8222

Fax (714) 497-0953

Hours

Monday-Friday:
9 am-6 pm (PT)
Saturday:
9 am-4 pm (PT)
Sunday: Closed

Care Point Pharmacy

Services patients in CA

Call (760) 669-0880

Fax (760) 669-5881

Hours

Monday-Friday:
9:30 am-6 pm (PT)
Saturday-Sunday:
Closed

Carrollton Regional Pharmacy

Services patients in TX

Call (469) 896-1777

Fax (469) 896-2777

Hours

Monday-Friday:
9 am-6 pm (CT)
Saturday-Sunday:
Closed

Colton Pharmacy

Services patients in AZ,CA

Call (909) 422-0444

Fax (909) 422-0459

Hours

Monday-Friday:
9:30 am-6 pm (PT)
Saturday:
9:30 am-1 pm (PT)
Sunday: Closed

HealthSource Pharmacy

Services patients in northeast region and FL

Call (212) 794-8700

Fax (212) 794-4979

Hours

Monday-Friday:
9 am-6 pm (ET)
Saturday:
Closed
Sunday:
10 am-3 pm (ET)

Lifeline Specialty Pharmacy

Services patients nationwide

Call (833) 454-3354

Fax (833) 785-4461

Hours

Monday-Friday:
9 am-6 pm (ET)
Saturday-Sunday:
Closed

Memorial Medical Pharmacy

Services patients nationwide

Call (818) 247-0526

Fax (818) 247-3076

Hours

Monday-Friday:
9 am-6 pm (PT)
Saturday:
9 am-1:30 pm (PT)
Sunday: Closed

Perigon Pharmacy

Services patients nationwide

Call (412) 684-2500

Fax (724) 597-7275

Hours

Pharmacist available 24/7

Placentia Linda Pharmacy

Services patients in CA

Call (714) 993-3345

Fax (714) 993-3344

Hours

Monday-Friday:
9:30 am-6 pm (PT)
Saturday-Sunday:
Closed

Polaris Pharmacy

Services patients nationwide

Call (855) 797-0857

Fax (800) 781-3364

Hours

Monday-Friday:
5:30 am-6 pm (PT)
Saturday-Sunday:
Closed

Synergen Rx Pharmacy

Services patients nationwide

Call (888) 975-2191

Fax (404) 900-9209

Hours

Monday-Friday:
8:30 am-5 pm (ET)
Saturday-Sunday:
Closed

Walgreens - nationwide

Address Phone number Hours of operation
10001 Chester Ave
Cleveland, OH 44106
(216) 416-7680 M-F 8:30 am-5:00 pm (ET);
Sat-Sun: Closed
1001 W. Carson St.
Torrance, CA 90502
(310) 953-0627 M-F: 8:30 am-5:00 pm (PT);
Sat-Sun: Closed
1015 Ripley St
Silver Spring, MD 20910
(301) 273-9526 M-F: 8:30 am-5:00 pm (ET);
Sat-Sun: Closed
1022 Walton Way
Augusta, GA 30901
(706) 619-2467 M-F: 8:30 am-5:00 pm (ET);
Sat-Sun: Closed
10990 Warner Ave Suite A
Fountain Valley, CA 92708
(714) 962-7200 M-F 9:00 am-6:00 pm;
Sat 10:00 am - 2:00 pm (PT);
Sun: Closed
1201 N Market St
Wilmington, DE 19801
(302) 660-3901 M-F: 8:30 am-5:30 pm (ET);
Sat-Sun: Closed
1215 NW 23rd Ave
Portland, OR 97210
(503) 937-4984 M-F: 8:30 am-6:00 pm (PT);
Sat-Sun: Closed
1250 NW 7th St
Miami, FL 33125
(305) 547-4790 M-F 8:00 am-5:30 pm;
Sat 8:00 am - 4:30 pm (PT);
Sun: Closed
1409 11th Ave
Seattle, WA 98122
(206) 324-2335 M-F 7:00 am-7:00 pm (PT);
Sat-Sun: Closed
1424 Union Ave
Memphis, TN 38104
(901) 725-7828 M-F 8:30 am-5:30 pm (CT);
Sat-Sun: Closed
1500 3rd St
Charlotte, NC 28204
(704) 526-4651 M-F: 9:00 am-5:30 pm (ET);
Sat-Sun: Closed
1520 Liliha St
Honolulu, HI 96817
(808) 533-6990 Mon-Tues 8:00 am-5:00 pm;
Wed 8:00 am-1:00 pm;
Thu-Fri 8:00-5:00 pm;
Sat 8:00 am-1:00 pm (HST)
Sun: Closed
1600 Haddon Ave
Camden, NJ 08103
(856) 757-9601 M-F 9:00 am-5:30 pm (ET);
Sat-Sun: Closed
1757 W San Carlos
San Jose, CA 95128
(408) 878-0112 M-F: 8:30 am-5:00 pm (PT);
Sat-Sun: Closed
1874 Piedmont Ave Ne
Atlanta, GA 30324
(404) 733-6800 M-F 8:00 am-6:00 pm;
Sat 9:00 am - 12:00 pm (ET);
Sun: Closed
201 Cedar St SE
Albuquerque, NM 87106
(505) 243-6195 M-F 8:00 am-6:00 pm (MT);
Sat-Sun: Closed
21 Stanhope St #23
Boston, MA 02116
(617) 375-7969 M-F 8:00 am-6:00 pm (ET);
Sat-Sun: Closed
2262 Market St
San Francisco, CA 94114
(415) 255-0101 M-F 9:00 am-7:00 pm (PT);
Sat-Sun: Closed
260 Stetson St
Cincinnati, OH 45219
(513) 878-3426 M-F: 8:30 am-5:00 pm (ET);
Sat-Sun: Closed
2668 Belvidere Rd
Waukegan, IL 60085
(847) 596-3604 M-F: 9:00 am-5:30 pm (CT);
Sat-Sun: Closed
3030 1st Ave N
St Petersburg, FL 33713
(727) 322-5200 Mon 9:00 am-5:30 pm;
Tues 9:00 am-6:30 pm;
Wed-Fri 9:00-5:30 pm (ET);
Sat-Sun: Closed
309C 22nd Ave N
Nashville, TN 37203
(615) 321-1808 M-F: 7:00 am-7:00 pm (CT);
Sat-Sun: Closed
3537 Broadway Blvd
Kansas City, MO 64111
(816) 561-1933 M-F 9:00 am-5:00 pm (CT);
Sat-Sun: Closed
3550 Market St
Philadelphia, PA 19104
(267) 892-3107 M-F: 9:00 am-5:00 pm (ET);
Sat-Sun: Closed
4201 Saint Antoine St
Detroit, MI 48201
(313) 966-8230 M-F: 8:00 am-6:00 pm (ET);
Sat-Sun: Closed
429 Brookline Ave
Boston, MA 02215
(617) 232-7506 M-F 8:00 am-6:00 pm (ET);
Sat-Sun: Closed
4339 Di Paolo Ctr
Glenview, IL 60025
(847) 299-1920 M-F 8:30 am-5:00 pm (CT);
Sat-Sun: Closed
500 S University Ave
Little Rock, AR 72205
(501) 664-4121 M-F 8:00 am-6:00 pm (CT);
Sat-Sun: Closed
5149 W Thunderbird Rd # 51
Glendale, AZ 85306
(602) 427-0919 M-F: 8:30 am-5:30 pm (MT);
Sat-Sun: Closed
532 S 4th St
Louisville, KY 40202
(502) 434-3122 M-F 8:30 am-5:00 pm (CT);
Sat-Sun: Closed
541 Hamilton St
Allentown, PA 18101
(484) 705-1783 M-F: 8:30 am-5:00 pm (ET);
Sat-Sun: Closed
550 16th St
San Francisco, CA 94158
(415) 365-0512 M-F: 9:00 am-6:00 pm;
Sat-Sun: 9 am-3:00 pm (PT)
5555 Essen Lane
Baton Rouge, LA 70809
(225) 508-3850 M-F: 8:30 am-5:00 pm (CT);
Sat-Sun: Closed
6 N Howard St
Baltimore, MD 21201
(410) 951-5940 M-F 9:00 am-5:30 pm (ET);
Sat-Sun: Closed
6395 Airport Blvd
Mobile, AL 36608
(251) 288-6077 Everyday: 8:00 am-10:00 pm (CT)
660 N Main Ave
San Antonio, TX 78205
(210) 924-6471 M-F: 8:30 am-5:00 pm (CT);
Sat-Sun: Closed
6624 Fannin St
Houston, TX 77030
(713) 795-0199 M-F 8:30 am-6:00 pm (CT);
Sat-Sun: Closed
826 N Plankinton Ave
Milwaukee, WI 53203
(414) 278-7828 M-F 8:00 am-5:00 pm (CT);
Sat-Sun: Closed
854 Purchase St
New Bedford, MA 02740
(508) 992-3209 M-F: 8:00 am-6:00 pm (ET);
Sat: 8 am-4:30 pm (ET)
901 S Rancho Dr
Las Vegas, NV 89106
(702) 471-7828 M-F 8:30 am-5:30 pm (PT);
Sat-Sun: Closed
Scroll to view more

RELATED LINKS

Access Support

How to Prescribe

Indication

XPHOZAH (tenapanor) 30 mg BID is indicated to reduce serum phosphorus in adults with chronic kidney disease (CKD) on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

Important Safety Information

Contraindications

XPHOZAH is contraindicated in:

  • Pediatric patients under 6 years of age
  • Patients with known or suspected mechanical gastrointestinal obstruction

Warnings and precautions

Diarrhea

Patients may experience severe diarrhea. Treatment with XPHOZAH should be discontinued in patients who develop severe diarrhea.

Most Common Adverse Reactions

Diarrhea, which occurred in 43-53% of patients, was the only adverse reaction reported in at least 5% of XPHOZAH-treated patients with CKD on dialysis across trials. The majority of diarrhea events in XPHOZAH-treated patients were reported to be mild-to-moderate in severity and resolved over time, or with dose reduction. Diarrhea was typically reported soon after initiation but could occur at any time during treatment with XPHOZAH. Severe diarrhea was reported in 5% of XPHOZAH-treated patients in these trials.

For additional safety information, please see full Prescribing Information.

Indication

XPHOZAH (tenapanor) 30 mg BID is indicated to reduce serum phosphorus in adults with chronic kidney disease (CKD) on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

Important Safety Information

Contraindications

XPHOZAH is contraindicated in:

  • Pediatric patients under 6 years of age
  • Patients with known or suspected mechanical gastrointestinal obstruction

Warnings and precautions

Diarrhea

Patients may experience severe diarrhea. Treatment with XPHOZAH should be discontinued in patients who develop severe diarrhea.

Most Common Adverse Reactions

Diarrhea, which occurred in 43-53% of patients, was the only adverse reaction reported in at least 5% of XPHOZAH-treated patients with CKD on dialysis across trials. The majority of diarrhea events in XPHOZAH-treated patients were reported to be mild-to-moderate in severity and resolved over time, or with dose reduction. Diarrhea was typically reported soon after initiation but could occur at any time during treatment with XPHOZAH. Severe diarrhea was reported in 5% of XPHOZAH-treated patients in these trials.

For additional safety information, please see full Prescribing Information.

Close

Connect with us for more information and continued updates about XPHOZAH.

Fill out the information below to register for updates.

*Required field.

Close

Close